Product Reports Resources Pricing Login Book a demo

Healx

Biotech & Life Sciences · Cambridge, United Kingdom · Founded 2014

AI-drug discovery accelerating treatments for rare diseases MoreLess

Healx is a pioneering company in the field of AI-driven drug discovery, focusing on developing new treatments for rare diseases. The company leverages advanced artificial intelligence to identify and accelerate the development of effective therapies for conditions that affect a small percentage of the population. Healx primarily serves patients with rare diseases, their families, and healthcare providers who are in dire need of innovative treatment options. Operating within the pharmaceutical and biotechnology markets, Healx collaborates with patient groups, research institutions, and pharmaceutical companies to expand its pipeline of potential treatments. The business model revolves around partnerships and collaborations, where Healx uses its proprietary AI technology to discover and repurpose drugs, thereby reducing the time and cost associated with traditional drug development. Revenue is generated through licensing agreements, milestone payments, and royalties from successfully developed therapies.

Keywords: AI drug discovery, rare diseases, pharmaceutical, biotechnology, patient groups, partnerships, drug repurposing, healthcare innovation, treatment development, licensing agreements.

Company overview

Healx company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2014
Headquarters
Cambridge, United Kingdom
Employees
70
Open positions
None listed
Dealroom signal
73.3
client focusb2btechnologyArtificial IntelligencetechnologyDeep TechtechnologyMachine LearningtechnologyDeep Learningsub industryBioTechnologyindustryHealthsectorBiotechnologysectorDrug DevelopmentsectorCore AIsectorSpinoutsectorDiseasesectorSustainable Development GoalssectorTech for Biotech and Pharma

Valuation & funding

Healx funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCOther financing Jul 2025 $0 SCI Ventures
SERIES COther financing Aug 2024 $47M $188M Balderton Capital · b2venture · VU Venture Partners · Atomico
LATE VCOther financing Nov 2023 $22M $280M Atomico · Balderton Capital · Global Brain Corporation · VU Venture Partners
SUPPORT PROGRAMOther financing Mar 2020 $0 Tech Nation
SERIES BOther financing Oct 2019 $56M $224M Intel Capital · Global Brain Corporation · Amadeus Capital Partners · Balderton Capital
SERIES AOther financing Jul 2018 Jonathan Milner · Balderton Capital · Amadeus Capital Partners
SERIES AOther financing Oct 2016 Amadeus Capital Partners · Jonathan Milner
SUPPORT PROGRAMOther financing Mar 2016 Pitch@Palace
SPINOUTOther financing Apr 2014 Cambridge Enterprise · University of Cambridge
Showing 9 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMargin
2026 $331K 0% −$37M -11170.8%
2025 $331K 0% −$37M -11170.8%
2024 $331K 0% −$37M -11170.8%
2023 $331K 0% −$37M -11170.8%
2022 $331K -16.7% −$37M -11170.8%
2021 $398K +67.3% −$24M -6099.6%
2020 $238K −$12M -4906.4%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Healx website traffic

Latest recorded traffic for Healx is 7.5K monthly website visits, up 21% over the last three months. Healx's team grew 6.1% over the past year.

Latest monthly visits7.5K 3-month web change+21% 1-year team growth+6.1%
Monthly website visits93 observations · Jan 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Healx compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Healx's talent

Book a demo to see the people
Team profiled 27 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

16 investors on Healx's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 7 investors entered at this stage
Series B+ 5 investors entered at this stage
VU Venture Partners
Ayana capital
R42 Group
O2h Ventures
SCI Ventures
Other known 4 additional known investors
Cambridge Enterprise
Pitch@Palace
Tech Nation
University of Cambridge

Global footprint

Where Healx has talent and traffic

Workforce by country
9 countries with
team presence
🇬🇧 United Kingdom70%
🇺🇸 United States10%
🇪🇸 Spain4%
🇩🇪 Germany4%
🇨🇭 Switzerland4%
Top 5 of 9 shown

In the news

Latest news about Healx

Recent press, funding announcements, and product moves mentioning Healx — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Healx

An AI-synthesized read of the highest-engagement posts about Healx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Healx’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.